MELISSA ALBERT: Open Payments
NPI 1033313911 · MORGANTOWN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 39 payments from 13 companies in 2025. Trend: 2023 $797 · 2024 $900 · 2025 $668
Food & beverage: $668
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $138 |
| Alkermes, Inc. | 5 | $109 |
| Otsuka America Pharmaceutical, Inc. | 3 | $88 |
| Novo Nordisk Inc | 4 | $81 |
| Corium, LLC | 6 | $76 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Exact Sciences Corporation | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Sage Therapeutics, LLC | 1 | $17 |
Products named: VRAYLAR, Azstarys, VIVITROL, REXULTI, Wegovy, ARISTADA, INGREZZA, UBRELVY.
Industry payments across WV — which companies pay providers there.
